CALLUNA PHARMA AS
932255189ActiveClinical stage biotech pioneering antibodies for inflammation and fibrosis.
Biotechnology Companycallunapharma.com
Oversigt
- 10
- Medarbejdere
- 26.9mio NOK
- Omsætning
- 2023
- Grundlagt
Nøglebeslutningstagere
Susanne Stuffers MD PhD
Board member
Caroline Kurtz
Chief Scientific Officer
Gijs van den Brink MD PhD
Board member
Vincent Loon
Observer to the Board
+8 flere kontakter i Funnelfeedr
Beskrivelse
Calluna Pharma is a global biotechnology company specializing in developing therapeutics focused on inflammation and fibrosis. Driven by a lean, committed team, the company is currently in the clinical stage of development. Their innovative approach targets upstream disease amplifiers using first-in...
ScandiBio Therapeutics AB